14 DRUG PANELS • OPI/2000, PPX & TCA • 3 ADULTERANT CHECKS • 90 mL
14-Panel Propoxyphene, Tricyclic Antidepressant & High-Cutoff Opiate Drug Test Cup with Adulterant Checks
Broad preliminary drug screening with high-cutoff opiate, propoxyphene, TCA and specimen-validity panels.
This compact 90 mL urine drug test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, high-cutoff opiates, oxycodone, phencyclidine, propoxyphene, tricyclic antidepressants and marijuana.
Integrated creatinine, pH and specific-gravity checks support specimen-validity assessment. Collection, temperature verification, preliminary drug screening and adulterant checks take place in one self-contained device, with results available in approximately five minutes.
Product Highlights
Fourteen-Drug Screening Screens for AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP, PPX, TCA and THC.
Three Adulterant Checks Includes creatinine, pH and specific gravity to support specimen-validity assessment.
High-Cutoff Opiate Panel Screens morphine and related opiates at the listed OPI/2000 cutoff.
Propoxyphene Screening Includes a dedicated PPX panel at the listed 300 ng/mL cutoff.
TCA Screening Screens for tricyclic antidepressants at the listed 1,000 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI, OXY and PPX panels.
Results in Minutes Provides clear preliminary results in approximately five minutes.
One-Step Testing Collection, screening and specimen checks are completed using one device.
Compact 90 mL Capacity Provides practical collection capacity in an easy-to-handle format.
Leak-Resistant Lid Secure no-drip twist closure helps reduce leaks, spills and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Fourteen Drug Panels with OPI/2000, PPX, TCA and Specimen-Validity Checks A comprehensive compact option for healthcare facilities, occupational health clinics, treatment programs, collection sites, correctional settings and authorized workplace screening.
Drug Panels, Cutoff Levels and Adulterant Checks
Review the fourteen drug categories and three integrated specimen-validity checks included in this configuration.
| TEST STRIP |
TESTED DRUG OR CHECK |
ESTIMATED DETECTION TIME / CUTOFF |
|
AMP AMP AMP AMP AMP AMP AMP AMP AMP AMP
|
Amphetamines |
1–2 Days • 1,000 ng/mL |
|
BAR BAR BAR BAR BAR BAR BAR BAR BAR BAR
|
Barbiturates |
1–2 Days • 300 ng/mL |
|
BUP BUP BUP BUP BUP BUP BUP BUP BUP BUP
|
Buprenorphine |
2–6 Days • 10 ng/mL |
|
BZO BZO BZO BZO BZO BZO BZO BZO BZO BZO
|
Benzodiazepines |
1–2 Days • 300 ng/mL |
|
COC COC COC COC COC COC COC COC COC COC
|
Cocaine |
2–4 Days • 300 ng/mL |
|
MDMA MDMA MDMA MDMA MDMA MDMA MDMA MDMA
|
MDMA / Ecstasy |
2–4 Days • 500 ng/mL |
|
MET MET MET MET MET MET MET MET MET MET
|
Methamphetamine |
2–4 Days • 1,000 ng/mL |
|
MTD MTD MTD MTD MTD MTD MTD MTD MTD MTD
|
Methadone |
1–3 Days • 300 ng/mL |
|
OPI OPI OPI OPI OPI OPI OPI OPI OPI OPI
|
Morphine / Opiates |
2–3 Days • 2,000 ng/mL |
|
OXY OXY OXY OXY OXY OXY OXY OXY OXY OXY
|
Oxycodone |
1–3 Days • 100 ng/mL |
|
PCP PCP PCP PCP PCP PCP PCP PCP PCP PCP
|
Phencyclidine |
7–14 Days • 25 ng/mL |
|
PPX PPX PPX PPX PPX PPX PPX PPX PPX PPX
|
Propoxyphene |
Approximately 3 Days • 300 ng/mL |
|
TCA TCA TCA TCA TCA TCA TCA TCA TCA TCA
|
Tricyclic Antidepressants |
2–3 Days • 1,000 ng/mL |
|
THC THC THC THC THC THC THC THC THC THC
|
Marijuana |
5+ Days • 50 ng/mL |
|
CR pH SG
|
Three Adulterant Checks |
Creatinine, pH and Specific Gravity |
Please Note: Detection windows vary by dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors. Refer to the manufacturer’s package insert for exact cutoff levels, adulterant ranges and interpretation instructions.
High-Cutoff Opiate Screening The OPI/2000 panel screens morphine and related opiates at 2,000 ng/mL. This is separate from the dedicated BUP, MTD, OXY and PPX panels, which should each be interpreted independently.
Integrated Specimen-Validity Checks Creatinine, pH and specific gravity help identify specimen characteristics that may be associated with dilution, substitution or possible manipulation. Review each result against the manufacturer’s color chart.
Propoxyphene and TCA Coverage The dedicated PPX and TCA panels expand screening beyond commonly included workplace drugs. The TCA panel screens a drug class and does not identify a particular medication or determine concentration.

How to Use the 14-Panel Propoxyphene, Tricyclic Antidepressant & High-Cutoff Opiate Drug Test Cup with Adulterant Checks

Understanding the 14-Panel Propoxyphene, Tricyclic Antidepressant & High-Cutoff Opiate Drug Test Cup with Adulterant Checks Drug Test Results

Product Dimensions and Specifications
| 14-Panel Compact Drug Test Cup with Adulterant Checks |
| Drug Panels |
AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP, PPX, TCA and THC |
| Adulterant Checks |
Creatinine, pH and Specific Gravity |
| Opiate Cutoff |
OPI/2000 |
| Propoxyphene Cutoff |
PPX/300 |
| TCA Cutoff |
TCA/1000 |
| Oxycodone Cutoff |
OXY/100 |
| Result Time |
Approximately 5 minutes |
| Capacity |
90 mL |
| Height |
2.53 inches |
| Bottom Width |
2.12 inches |
| Lid Width |
2.75 inches |
| Approximate Weight |
0.14 lb |
CLIA Waived and FDA 510(k) Cleared
Where this exact 14-panel configuration is labeled CLIA Waived and FDA 510(k) Cleared, it may be used for the intended purposes identified in the manufacturer’s labeling and in eligible point-of-care settings operating under a CLIA Certificate of Waiver.
What CLIA Waived Means The test is categorized as simple to perform and may be used by eligible sites holding a CLIA Certificate of Waiver when the manufacturer’s instructions are followed exactly.
What FDA 510(k) Cleared Means The device has completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.
Depending on the exact labeling and applicable requirements, this cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites, probation and correctional programs, law-enforcement settings and qualifying workplace-screening programs.
Regulatory Notice: FDA clearance and CLIA-waived status are separate designations and may vary by exact product configuration or individual assay. Confirm the regulatory status shown on the package labeling before advertising, purchasing or use.
Frequently Asked Questions
1. Which substances does this 14-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine, propoxyphene, tricyclic antidepressants and marijuana.
2. What does OPI/2000 mean? OPI/2000 indicates that the morphine and opiate panel uses a 2,000 ng/mL preliminary screening cutoff.
3. Does it include propoxyphene and TCA screening? Yes. It includes a PPX panel at 300 ng/mL and a tricyclic antidepressant panel at 1,000 ng/mL.
4. What specimen-validity checks are included? The cup includes creatinine, pH and specific-gravity checks to support specimen-validity assessment.
5. How quickly are results available? Preliminary results are available in approximately five minutes. Results should not be interpreted after eight minutes or outside the manufacturer’s stated reading window.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, legal or treatment decisions are made.
Fourteen Drug Panels. OPI/2000, PPX and TCA Screening. Three Adulterant Checks. Simplify broad preliminary urine drug screening with a compact, self-contained 90 mL cup designed for secure collection, specimen-validity assessment and easy visual interpretation.
Order 14-Panel Compact Test Cups Today